Rett syndrome clinical trials
Other conditions
19 trials are recruiting, according to ClinicalTrials.gov.
Checked against the registry on 22 November 2026. Listing a trial here is not a recommendation; taking part is voluntary and each study team decides who is eligible.
A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome
Ages 5 Years to 35 Years · 46 sites · UCB BIOSCIENCES, Inc.
Details and how to check if you qualify · NCT07503444 on ClinicalTrials.gov
Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome
Ages 4 Years to 25 Years · 1 site · Fenix Innovation Group
To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
Ages 5 Years to 20 Years · 18 sites · Biomed Industries, Inc.
A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome
Ages 2 Years to 21 Years · 1 site · Holland Bloorview Kids Rehabilitation Hospital
Adapting a Psychosocial Support Intervention for the Rett Syndrome Community
Ages 18 Years to no maximum · 1 site · Colorado State University
Rett REVOLUTION Trial: An Exploratory Evaluation of the Safety and Efficacy of Vorinostat in Rett Syndrome
Ages 6 Years to 21 Years · 1 site · Unravel Biosciences, Inc.
Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders
Ages 4 Years to 12 Years · 1 site · Healing Hope International
Lamivudine as a Novel Clinical Effort for Rett Syndrome
Ages 2 Years to no maximum · 1 site · Maria Denise Fernandes Carvalho de Andrade
Auditory EEG and Behavioral Assessments in Individuals With Rett Syndrome
Ages 2 Years to no maximum · 1 site · University of Rochester
Repurposing Mirtazapine in Rett Syndrome
Ages 5 Years to 40 Years · 4 sites · University of Trieste
Cognitive Function in Rett Syndrome During Trofinetide Treatment
Ages 18 Years to 99 Years · 1 site · University of Minnesota
GCB-002 in Treatment of Patients With Rett Syndrome
Ages 2 Years to 10 Years · 1 site · Genecombio Ltd.
ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)
Ages 2 Years to 65 Years · 12 sites · Ionis Pharmaceuticals, Inc.
Neurophysiologic Biomarkers in Rett Syndrome
Ages 1 Year to 18 Years · 6 sites · Children's Hospital of Philadelphia
Rett Syndrome Registry
Ages 0 Years to 99 Years · 19 sites · International Rett Syndrome Foundation
The Rett Syndrome Global Registry
Ages No minimum to no maximum · 1 site · Rett Syndrome Research Trust
Gene Editing as a Therapeutic Approach for Rett Syndrome
Ages 6 Months to no maximum · 1 site · University of Siena
Parent and Infant Inter(X)Action Intervention (PIXI)
Ages No minimum to 99 Years · 1 site · RTI International
GROWing Up With Rare GENEtic Syndromes
Ages 18 Years to no maximum · 1 site · dr. Laura C. G. de Graaff-Herder
More: Acne clinical trials · Alzheimer’s disease and related dementias clinical trials · Cannabis use disorder clinical trials · Chronic hives (chronic urticaria) clinical trials · COPD (chronic obstructive pulmonary disease) clinical trials · Depression clinical trials · Depression (major depressive disorder) clinical trials · Moderately to severely active crohn's disease clinical trials · Osteoporosis clinical trials